Curebase Appoints Holly Randolph as Senior Director of Quality & Compliance
Curebase is pleased to announce that Holly Randolph has joined the company as Senior Director of Quality & Compliance, strengthening the quality and regulatory foundation behind Curebase's next-gen eClinical platform as it scales across sponsors, CROs, and research sites.
Curebase's modern eClinical platform brings together recruitment tech, eConsent, eCOA/ePRO, EDC, and site technology in a single system that helps study teams launch trials faster and capture better data.
As adoption of the platform grows, so does the importance of the quality systems and regulatory rigor behind it. Holly will lead that work, helping ensure sponsors and CROs can trust the platform at every stage of a study.
A Proven Quality & Compliance Leader
"As Curebase grows, our commitment to quality and compliance has to grow right alongside it. Holly brings the depth of experience and the practical, hands-on approach we need to support that growth with confidence."— Storm Stillman, Chief Executive Officer of Curebase
Holly brings more than two decades of global quality assurance and compliance experience across pharmaceutical, biotech, and medical device organizations, including IQVIA, ObvioHealth, Sanofi, Merck, and Thermo Fisher Scientific.
Her background spans GCP and GMP regulations, quality systems and auditing, and direct experience with decentralized and hybrid clinical trials, giving her a practical understanding of the technology shaping modern research. She is an ASQ Certified Quality Auditor and Lean Six Sigma Green Belt.
"Curebase is at an exciting point in its growth, and quality is what makes that growth sustainable. I'm looking forward to working with the team to support sponsors, CROs, and sites with the same rigor and care they'd expect from any trusted research partner."— Holly Randolph, Senior Director of Quality & Compliance at Curebase
